47 Results

People

  1. Abramson
    Abramson
  2. Shoushtari
    Shoushtari
  3. Murali
    Murali
  4. Barker
    Barker
  5. Francis
    Francis
  6. Marr
    Marr
  7. Postow
    Postow
  8. Wiesner
    Wiesner
  9. Busam
    Busam
  10. Carvajal
    Carvajal

Groups

  1. Melanoma Disease Management Team (25)
  2. Department of Medicine (24)
  3. Solid Tumor Oncology Division (22)
  4. Hematologic Malignancies, Division of (21)
  5. Melanoma and Immunotherapeutics Service (20)
  6. Surgery (17)
  7. Department of Pathology and Laboratory Medicine (13)
  8. Pediatrics, Department of (11)
  9. GSK Faculty (9)
  10. GDMT, Pathology and Laboratory Medicine (8)
  1. "uveal melanoma"
Formats
  1. Journal Article (43)
  2. Review (3)
  3. Book Section (1)
Groups
  1. Melanoma Disease Management Team (25)
  2. Department of Medicine (24)
  3. Solid Tumor Oncology Division (22)
  4. Hematologic Malignancies, Division of (21)
  5. Melanoma and Immunotherapeutics Service (20)
  6. Surgery (17)

More Groups

People
  1. Alexander Shoushtari (18)
  2. Jasmine Francis (12)
  3. David Abramson (11)
  4. Rajmohan Murali (8)
  5. Christopher Barker (7)
  6. Brian Marr (5)

More People

Years
  1. 2025 (2)
  2. 2024 (5)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (1)
  6. 2020 (2)

More Years

Publications
  1. Ocular Oncology and Pathology (4)
  2. Cancer (3)
  3. Frontiers in Oncology (3)
  4. Melanoma Research (3)
  5. Pathology (3)
  6. Cancers (2)

More Publications

Publishers
  1. Karger (4)
  2. Lippincott Williams & Wilkins (4)
  3. Wiley Blackwell (4)
  4. Royal College of Pathologists of Australasia (3)
  5. Biomed Central Ltd (3)
  6. Cell Press (3)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
    Journal Article

    Wei, A. Z.; Uriel, M.; Porcu, A.; Manos, M. P.; Mercurio, A. C.; Caplan, M. M.; Hulse, L.; Seedor, R. S.; Holovatska, M.; Francis, J.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
    Journal Article

    Khan, S.; Patel, S. P.; Shoushtari, A. N.; Ambrosini, G.; Cremers, S.; Lee, S.; Franks, L.; Singh-Kandah, S.; Hernandez, S.; Sender, N.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
    Journal Article

    Khan, S.; Lutzky, J.; Shoushtari, A. N.; Jeter, J.; Marr, B.; Olencki, T. E.; Cebulla, C. M.; Abdel-Rahman, M.; Harbour, J. W.; Sender, N.; more...
    Frontiers in Oncology (2022)

    Fulltext@MSK | Save
  • Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells
    Journal Article

    North, K.; Benbarche, S.; Liu, B.; Pangallo, J.; Chen, S.; Stahl, M.; Bewersdorf, J. P.; Stanley, R. F.; Erickson, C.; Cho, H.; more...
    Nature Biotechnology (2022)

    Fulltext@MSK | Save
  • Uveal melanoma metastatic at initial diagnosis: A case series
    Journal Article

    Steckler, A. M.; Francis, J. H.; Shoushtari, A. N.; Abramson, D. H.; Barker, C. A.
    Melanoma Research (2022)

    Fulltext@MSK | Save
  • A phase Ib study of sotrastaurin, a PKC inhibitor, and alpelisib, a PI3Kα inhibitor, in patients with metastatic uveal melanoma
    Journal Article

    Shoushtari, A. N.; Khan, S.; Komatsubara, K.; Feun, L.; Acquavella, N.; Singh-Kandah, S.; Negri, T.; Nesson, A.; Abbate, K.; Cremers, S.; more...
    Cancers (2021)

    Fulltext@MSK | Save
  • Tebentafusp, a TCR/anti-CD3 bispecific fusion protein targeting gp100, potently activated antitumor immune responses in patients with metastatic melanoma
    Journal Article

    Middleton, M. R.; McAlpine, C.; Woodcock, V. K.; Corrie, P.; Infante, J. R.; Steven, N. M.; Evans, T. R. J.; Anthoney, A.; Shoushtari, A. N.; Hamid, O.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
    Journal Article

    Klemen, N. D.; Wang, M.; Rubinstein, J. C.; Olino, K.; Clune, J.; Ariyan, S.; Cha, C.; Weiss, S. A.; Kluger, H. M.; Sznol, M.
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Uveal Melanoma
    Book Section

    Francis, J. H.; Busam, K. J.
    In Busam, K. J.; Scolyer, R. A.; Gerami, P. (Eds.) Pathology of Melanocytic Tumors (2019)

    Fulltext@MSK | Save
  • Chemoreduction of orbital recurrence of uveal melanoma by intra-arterial melphalan
    Journal Article

    Francis, J. H.; Barker, C. A.; Yin, V. T.; Carvajal, R. D.; Chapman, P.; Abramson, D. H.; Gobin, Y. P.
    Ocular Oncology and Pathology (2019)

    Fulltext@MSK | Save